Revisiting the effect compartment through timing errors in drug administration

被引:21
作者
Nony, P [1 ]
Cucherat, M [1 ]
Boissel, JP [1 ]
机构
[1] Cardiovasc Hosp, Div Pharmacol, F-69003 Lyon, France
关键词
D O I
10.1016/S0165-6147(97)01159-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The variations in the pharmacological effects induced by timing errors in drug intake are compared for two drugs, one acting by way of an effect compartment and the other directly from the central compartment. A simulation was performed for two drugs having the same concentration-effect relationship at the receptor site, the same mean effect at equilibrium and identical concentrations in the central compartment. In this article, Patrice Nony, Michel Cucherat and Jean-Pierre Boissel discuss how, for the same variability of concentrations in the central compartment, the variations in mean effects are different. When there is large variability in the interval separating two consecutive doses, the model that includes an effect compartment dampens the pharmacokinetic variability present in the central compartment. Such an approach may be useful for the prescription recommendations of drugs, especially those with narrow therapeutic indices.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 25 条
  • [1] EFFECT OF PROPRANOLOL ON THE MYOCARDIAL-CONTRACTILITY OF NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RABBITS - RELATIONSHIP OF PHARMACOKINETICS AND PHARMACODYNAMICS
    CORBO, M
    WANG, PR
    LI, JKJ
    CHIEN, YW
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1989, 17 (05): : 551 - 570
  • [2] HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE
    CRAMER, JA
    MATTSON, RH
    PREVEY, ML
    SCHEYER, RD
    OUELLETTE, VL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22): : 3273 - 3277
  • [3] MORBIDITY AND MORTALITY IN THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP-HYPERTENSION)
    DAHLOF, B
    LINDHOLM, LH
    HANSSON, L
    SCHERSTEN, B
    EKBOM, T
    WESTER, PO
    [J]. LANCET, 1991, 338 (8778) : 1281 - 1285
  • [4] COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES
    DAYNEKA, NL
    GARG, V
    JUSKO, WJ
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04): : 457 - 478
  • [5] PHARMACODYNAMIC MODELING OF THE ANTIHYPERTENSIVE RESPONSE TO AMLODIPINE
    DONNELLY, R
    MEREDITH, PA
    MILLER, SHK
    HOWIE, CA
    ELLIOTT, HL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (03) : 303 - 310
  • [6] EFRON B, 1991, J AM STAT ASSOC, V86, P7
  • [7] GABRIELSSON J, 1994, PHARMACOKINETIC PHAR, P523
  • [8] Gibaldi M. P., 1982, PHARMACOKINETICS
  • [9] Haynes RB TD., 1979, COMPLIANCE HLTH CARE
  • [10] PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF CIBENZOLINE PLASMA-CONCENTRATIONS AND ANTIARRHYTHMIC EFFECT
    HOLAZO, AA
    BRAZZELL, RK
    COLBURN, WA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (05) : 336 - 345